Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer
A phase 3 trial of Dexrazoxane, Doxorubicin, Cyclophosphamide, Paclitaxel / nab-paclitaxel, Trastuzumab and Tamoxifen in Inflammatory breast cancer and Breast cancer, run by National Cancer Institute (NCI), recorded as terminated on the registry.
Overview
Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer is a phase 3 interventional study registered as NCT00016276 by National Cancer Institute (NCI), with 396 participants recorded, started 2001-05 and due to reach its primary completion in 2005-03. Interventions recorded: dexrazoxane hydrochloride, doxorubicin hydrochloride, cyclophosphamide, paclitaxel, trastuzumab, therapeutic conventional surgery, radiation therapy, tamoxifen citrate, laboratory biomarker analysis. Conditions recorded: Cardiac Toxicity, Inflammatory Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer.
Linked to the drug Dexrazoxane because the registry names it among its interventions and Inflammatory breast cancer and Breast cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialChemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Shares Breast cancer (all types), Cyclophosphamide, Trastuzumab, Doxorubicin and the tag pipeline.
- TrialPrevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell Lymphoma
Shares Dexrazoxane, Cyclophosphamide, Doxorubicin and the tag pipeline.
- TrialTriptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
Shares Tamoxifen, Breast cancer (all types) and the tag pipeline.
- TrialEfficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast Cancer
Shares Tamoxifen, Breast cancer (all types) and the tag pipeline.
- TrialMARGetuximab Or Trastuzumab (MARGOT)
Shares Breast cancer (all types), Trastuzumab, Paclitaxel / nab-paclitaxel and the tag pipeline.
- TrialSix vs 12 Months of Trastuzumab With Docetaxel Following FEC as Adjuvant Treatment in N+ Breast Cancer
Shares Breast cancer (all types), Cyclophosphamide, Trastuzumab and the tag pipeline.
- TrialRandomized Phase III Trial Comparing Sequential Administration of FE75C Followed by Docetaxel Versus Paclitaxel as Adjuvant Chemotherapy in Axillary Lymph Node (+) Breast Cancer
Shares Breast cancer (all types), Cyclophosphamide, Paclitaxel / nab-paclitaxel and the tag pipeline.
- TrialHOBOE: A Phase 3 Study of Adjuvant Triptorelin and Tamoxifen, Letrozole, or Letrozole and Zoledronic Acid in Premenopausal Patients With Breast Cancer
Shares Tamoxifen, Breast cancer (all types) and the tag pipeline.